BANK VONTOBEL/PUT/CVS HEALTH/60/0.1/20.09.24 Stock

Warrant

DE000VM3MXD3

Delayed Deutsche Boerse AG 07:55:19 2024-07-03 am EDT
0.42 EUR -2.33% Intraday chart for BANK VONTOBEL/PUT/CVS HEALTH/60/0.1/20.09.24
Current month+19.44%
1 month+4.88%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-03 0.42 -2.33%
24-07-02 0.43 +13.16%
24-07-01 0.38 +5.56%
24-06-28 0.36 -12.20%
24-06-27 0.41 +51.85%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 07:55 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM3MXD
ISINDE000VM3MXD3
Date issued 2023-10-06
Strike 60 $
Maturity 2024-09-20 (79 Days)
Parity 10 : 1
Emission price 0.33
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.74
Lowest since issue 0.038
Spread 0.01
Spread %2.27%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
57.52 USD
Average target price
69.1 USD
Spread / Average Target
+20.12%
Consensus